1910 Genetics is a biotech company using AI and biology to speed up drug discovery. As its science matured, its digital systems fell behind. The website didn’t reflect the complexity of its work or the expectations of partners and investors.
They needed a transparent, scalable platform to support SEO, explain research, and meet compliance standards without slowing down their internal team.
Before the rebuild, 1910 Genetics faced several challenges:
They needed a digital system to meet investor expectations, communicate clearly, and grow with the company.
Digital NYC did a custom website rebuild—focusing on clarity, performance, and control.
We started by mapping the site around specific audiences: investors, partners, and researchers.
The previous site had no structured SEO. We introduced a complete visibility plan using the following:
Keywords were mapped to investor discovery, AI drug development, and platform-specific searches.
The build used Next.js + React, which was deployed on Vercel for fast, scalable hosting.
Biotech companies must meet strict content and accessibility requirements. We made sure every page aligned with the following:
The entire project took 12 weeks from start to launch:
The new system helped grow traffic from under 5,000 monthly visits to over 17,700 monthly organic sessions.
This was achieved without paid ads—driven entirely by search improvements, structure, and technical fixes.
These gains reflect targeted biotech discovery, research, and platform innovation coverage.
This wasn’t a fundamental redesign. It was a rebuild grounded in strategy and compliance. Success came from aligning every system piece with the company’s actual needs—visibility, trust, and speed.
From raising a round, publishing research or launching a new platform—your digital system must reflect your vision and meet industry standards.
%402x.svg){kind=icon}
